Government Health Care Consulting and Advisory Services has been saved
Services
Government Health Care Consulting and Advisory Services
Advancing and innovating public health, health care, and biomedical science
The world of health care is going through a major transformation. Exciting technologies like generative artificial intelligence (GenAI), along with improvements in patient-centered care and biomedical innovation, are changing the way we approach health. At Deloitte, we have the expertise to help federal health agencies drive this transformation for the current and future generations. How can we assist you in reaching your goals?
What we do
Harness change to drive innovation
Federal health leaders face unprecedented challenges, having recently dealt with a global pandemic that transformed health research, delivery, and treatment. Now, as federal health agencies shift their focus to the next phase of health care, such as using advanced digital technologies to address public health crises or using data and analytics for crucial results, success lies in embracing change to drive innovation and achieve essential outcomes.
Deloitte brings extensive experience in both the health care industry and across federal health agencies, along with our involvement in strategic partnerships and research-based insights. We are here to assist federal health agencies in solving complex problems, preparing for the future, and improving community and national health outcomes.
Ready to navigate the future of health care together? Contact us now.
Our Federal Health offerings: Define and deliver the Future of Health™
Our consulting services are tailored to help federal health agencies overcome the challenges of today’s rapidly changing landscape. We understand the importance of data, research, and mission transformation, and we can guide you in defining and delivering the future of health. Our programs and technologies are designed to put people at the center and create positive impact for our clients and broader society. Learn more about what makes us different!
Technology Services
 |
Cancer AI AllianceDeloitte is proud to be a Foundational Partner of the newly formed Cancer AI Alliance (CAIA). Deloitte, alongside AWS, Microsoft, and NVIDIA, is partnering with four Cancer Institutes - Dana-Farber Cancer Institute, Fred Hutch Cancer Center, emorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins - to help reinvent how cancer data is shared and research is conducted across the nation. The alliance will apply responsible AI to the collective power of the participating cancer centers’ data to unlock insights while protecting data security, all in the name of accelerating and advancing cancer research. It will serve as a collaboration hub, providing shared infrastructure and data standardization, which will shift the cancer research domain closer toward team science (vs. science in isolation), accelerate the speed of insights and innovation and improve health outcomes. Read more about this groundbreaking collaboration here. |
Get in touch
Recommendations
Unlocking the potential of biomedical innovation: The crucial role the government and partnerships play in accelerating progress
Government can support the biomedical and health ecosystem by providing frameworks, resources, and last-mile infrastructure to help foster disruptive innovation.
CDO Playbook 2023
Discover the tools and resources government chief data officers can use as their role and that of data in general expand.